指南与共识消化道肿瘤与早癌消化内镜

疑似结直肠癌症状患者粪便免疫化学检测(FIT):大不列颠及爱尔兰结直肠病学协会(ACPGBI)与英国胃肠病学会(BSG)联合指南

Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG).
指南 / 共识 · Gut · 2022-07-12

该联合指南由21人多学科指南制定组制定,基于对13535篇文献的系统综述,形成23条证据与专家意见推荐,用于初级保健中对有疑似结直肠癌症状者进行分诊。FIT对结直肠癌检测敏感性高,作为客观风险指标其阳性预测值远优于仅用症状,并可识别真正低风险人群。指南还通过扩展德尔菲法在关键利益相关方中达成共识,并优先提出17条研究建议。

要点

  • FIT对结直肠癌检测敏感性高,可作为症状人群客观风险指标。
  • FIT阳性预测值远优于仅用症状,并可识别真正低风险人群。
  • 指南形成23条证据与专家意见推荐,用于初级保健疑似结直肠癌症状分诊。

核心结论

  • FIT对结直肠癌检测敏感性高,在症状人群中可识别需最高优先级结直肠检查的患者。
  • FIT作为客观风险指标,其阳性预测值远优于仅用症状,并可识别真正低风险人群。

研究设计与样本

  • 由大不列颠及爱尔兰结直肠病学协会与英国胃肠病学会联合制定,由21人多学科指南制定组完成。
  • 系统综述纳入13535篇文献,形成23条证据与专家意见推荐,用于初级保健疑似结直肠癌症状分诊。
  • 通过扩展德尔菲法在指南制定组及英国和爱尔兰另外61名个人中达成共识,包括公众、慈善机构及初级和二级保健成员。

主要发现

  • FIT对结直肠癌检测敏感性高。
  • 在症状人群中FIT可识别需最高优先级结直肠检查的患者。
  • FIT作为客观风险指标,其阳性预测值远优于仅用症状,并可识别真正低风险人群。

关键数值与推荐

  • 形成23条证据与专家意见推荐,用于初级保健疑似结直肠癌症状分诊。
  • 优先提出17条研究建议以指导临床管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Faecal immunochemical testing (FIT) has a high sensitivity for the detection of colorectal cancer (CRC). In a symptomatic population FIT may identify those patients who require colorectal investigation with the highest priority. FIT offers considerable advantages over the use of symptoms alone, as an objective measure of risk with a vastly superior positive predictive value for CRC, while conversely identifying a truly low risk cohort of patients. The aim of this guideline was to provide a clear strategy for the use of FIT in the diagnostic pathway of people with signs or symptoms of a suspected diagnosis of CRC. The guideline was jointly developed by the Association of Coloproctology of Great Britain and Ireland/British Society of Gastroenterology, specifically by a 21-member multidisciplinary guideline development group (GDG). A systematic review of 13 535 publications was undertaken to develop 23 evidence and expert opinion-based recommendations for the triage of people with symptoms of a suspected CRC diagnosis in primary care. In order to achieve consensus among a broad group of key stakeholders, we completed an extended Delphi of the GDG, and also 61 other individuals across the UK and Ireland, including by members of the public, charities and primary and secondary care. Seventeen research recommendations were also prioritised to inform clinical management.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Monahan KJ, Davies MM, Abulafi M, et al. Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG). Gut. 2022. PMID: 35820780. doi:10.1136/gutjnl-2022-327985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。